Morgan Stanley’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Buy |
|
|||||
|
2025
Q1 | $1.96M | Sell |
|
|||||
|
2024
Q4 | $15.7M | Buy |
|
|||||
|
2024
Q3 | $664K | Buy |
|
|||||
|
2024
Q2 | $256K | Buy |
|
|||||
|
2024
Q1 | $393K | Sell |
|
|||||
|
2023
Q4 | $921K | Buy |
|
|||||
|
2023
Q3 | $173K | Sell |
|
|||||
|
2023
Q2 | $350K | Buy |
|
|||||
|
2023
Q1 | $298K | Sell |
|
|||||
|
2022
Q4 | $820K | Sell |
|
|||||
|
2022
Q3 | $996K | Sell |
|
|||||
|
2022
Q2 | $1.35M | Buy |
|
|||||
|
2022
Q1 | $1.89M | Sell |
|
|||||
|
2021
Q4 | $2.77M | Buy |
|
|||||
|
2021
Q3 | $2.09M | Buy |
|